Ideal Biohacking Longevity Marketing Agencies

Biohacking and longevity brands need advertising companies with details competence in compliant health claims, informed customer target markets, and the scientific content approach that develops rely on this classification. Settings two with nine were chosen from agencies operating either as broader DTC ecom companies with biohacking-adjacent supplement and gadget customers, healthcare-focused agencies with durability and recovery vertical experience, or bigger generalist firms with implementation capacity.

Best for: biohacking brands throughout workshops, devices, supplements, and clinical services doing $50K+ regular monthly profits that want an expert who has really scaled biohacking-category brands as opposed to a generalist DTC shop using ecom playbooks.

Best for: biohacking supplement and device brand names operating inside bigger DTC portfolio holdings (multi-brand ecom roll-ups, supplement sector consolidators) where Power Digital's portfolio-level analytics system Nova supplies cross-brand acknowledgment at scale.

A content, non-pay-to-play ranking of the biohacking advertising agencies worth talking to in 2026, placed on Special Advertisement Category tool, fluency and peptide conformity rigor, and revealed case study results throughout the biohacking group.

Initially, fluency throughout the biohacking podcast advertising environment (Huberman Lab, The Drive with Peter Attia, Ben Greenfield Life, Bulletproof Radio, Joe Rogan Experience, Tim Ferriss Show) due to the fact that biohacking customers consume long-form podcast content during research greater than customers in surrounding wellness classifications.

Flaming Firm is the health Marketing agency for biohacking studios expert behind two of the biggest divulged study in the biohacking-adjacent device area: $7 million in HBOT chamber sales throughout home, med health facility, surgery facility, hospital, and durability facility purchasers, and 700 cool plunge storage tanks marketed across home, studio, and clinical buyers.